Mechanically Milled Co_1-xFe_xO₄ Nanocrystalline for Magnetic Hyperthermia Application

Abstract:

Mechanical alloying of a mixture of Fe₂O₃ and CoO powders has been applied for the preparation of nanocrystalline. Utilizing a ball-to-powder mass ratio of 20, milling time of 20 hours followed by annealing at 900°C, we could obtain a nanocrystalline of high crystallinity and composed of mainly CoFe₂O₄ phase with presence of Fe₂O₃ as revealed by X-ray diffraction (XRD) measurements. Magnetic measurements using vibrating sample magnetometer (VSM) reveal high saturation magnetization for the annealed sample close to CoFe₂O₄ phase value. The heating efficiency of the obtained nanocrystalline is studied under an alternating magnetic field and as a function of the concentration. It was found that the nanocrystalline generate a substantial amount of heat when exposed to an alternating magnetic field. In vitro hyperthermia experiment was carried out and our result clearly demonstrates the ability of the obtained nanocrystalline to kill cancer cell through magnetic hyperthermia.

• Periodical: Journal of Nano Research (Volume 59)
• Pages: 25-34
• DOI: https://doi.org/10.4028/www.scientific.net/JNanoR.59.25
• Online since: August 2019
• Authors: O.M. Lemine*, Sharif Abu Alrub
• Keywords: Ferrite, Magnetic Hyperthermia, Magnetic Nanocrystalline, SQUID, XRD

References

[1] A. Jordan, P. Wust, H. Fahling, W. John, A. Hinz and R. Felix, Inductive heating of ferrimagnetic particles and magnetic fluids: physical evaluation of their potential for hyperthermia. International Journal of Hyperthermia. 9 (1993) 51-68.

DOI: 10.3109/02656739309061478

[2] H. Basti, L. Ben Tahar, L.S. Smiri, F. Herbst, M.J. Vaulay, F. Chau, S. Ammar, S. Benderbous, Catechol derivatives-coated Fe3O4 and gamma-Fe2O3 nanoparticles as potential MRI contrast agents. J. Colloid Interface Sci. 341 (2010) 248–54.

DOI: 10.1016/j.jcis.2009.09.043

[3] P.B. Shete, R.M. Patil, N.D. Thorat, A. Prasad, R.S. Ningthoujam, S.J. Ghosh and S.H. Pawar, Magnetic chitosan nanocomposite for hyperthermia therapy application: Preparation, characterization and in vitro experiments. Appl. Surf. Sci. 288 (2014) 149–157.

DOI: 10.1016/j.apsusc.2013.09.169

[4] N.D. Thorat, O.M. Lemine, A. Raghvendra, K. Omri, K, L. El Mir and S.A.M. Tofail, Superparamagnetic iron oxide nanocargoes for combined cancer thermotherapy and MRI applications. Physical Chemistry Chemical Physics, 18 (2016) 21331 – 21339.

DOI: 10.1039/c6cp03430f

[5] O.M. Lemine, K. Omri, K, L. El Mir, V. Velasco, P. Crespo, P. De Presa, H. Bouzid, A. Youssif and A. Hajry, Fe2O3 nanoparticles for magnetic hyperthermia applications. Mater. Res. Soc. Symp. Proc. 1779 (2015) 7-13.

DOI: 10.1557/opl.2015.697

[6] M. Iglesias, V. Velasco, O.M. Lemine, K. Omri, L. El Mir, H. Bouzid, A. Youssif, A. Hajry, P. Crespo, P. De la Presa, γ-Fe2O3 nanoparticles obtained by sol-gel: dependence of magnetism and heating efficiency on particle size, INTERMAG Proc (2014) , May 4-8, 2014 , Dresden , Germany.

DOI: 10.1016/j.jallcom.2014.04.002

[7] O.M. Lemine, K. Omri, K, L. El Mir, V. Velasco, P. Crespo, P. De Presa, H. Bouzid, A. Youssif and A. Hajry, A., γ-Fe2O3 by sol-gel With Large Nanoparticles Size for Magnetic Hyperthermia Application. Journal of Alloys and Compounds. 607 (2014) 125–131.

DOI: 10.1016/j.jallcom.2014.04.002

[8] P. De la Presa, Y. Luengo, M. Multigner, R. Costo, M.P. Morales, G. Rivero and A. Hernando, Study of Heating Efficiency as Function of Concentration, Size and Applied Field in γ-Fe2O3 Nanoparticles. The Journal of Physical Chemistry C. 116 (2012) 25602−25610.

DOI: 10.1021/jp310771p

[9] R.A. Bohara, N.D. Thorat, A.K. Chaurasi and S.H. Pawar, Cancer cell extinction through a magnetic fluid hyperthermia treatment produced by superparamagnetic Co–Zn ferrite nanoparticles. RSC Adv. 58(2015) 47225.

DOI: 10.1039/c5ra04553c

[10] E. Kita, S.Hashimoto, T. Kayano, M. Minagawa, H. Yanagihara, M. Kishimoto, K. Yamada, T. Oda, N. Ohkohchi, T. Takagi, T. Kanamori, Y. Ikehata and I. Nagano, Heating characteristics of ferromagnetic iron oxide nanoparticles for magnetic hyperthermia. Journal of Applied Physics. 107 (2010) 09B321-09B321.

DOI: 10.1063/1.3355917

[11] C. Martinez-Boubeta, K. Simeonidis, A. Makridis, M. Angelakeris, O. Iglesias, P. Guardia, A. Cabot, L. Yedra, S. Estrade, F. Peiro, Z. Saghi, P.A. Midgley, I. Conde-Leboran, D. Serantes, D. and D. Baldomir, Learning from nature to improve the heat generation of iron-oxide nanoparticles for magnetic hyperthermia applications. Sci. Rep. 3 (2010) 1652.

DOI: 10.1038/srep01652

[12] A.M. Al-Saie, M. Bououdina, A. Jaffar, S. Arekat, J.M. Melnyczu, Y.T. Thai and C.S. Brazel, The effect of annealing on the structure, magnetic properties and AC heating of CoFe2O4 for biomedical applications. Journal of Alloys and Compounds. 509 (2011) 393–396.

DOI: 10.1016/j.jallcom.2011.02.024

[13] R. Sani, A. Beitollahi, Y.V. Maksimov and I.P. Suzdalev, Synthesis, Phase Formation Study and Magnetic Properties of CoFe2O4 Nanopowder Prepared by Mechanical Milling. Journal of Materials Science. 42(2007) 2126-2131.

DOI: 10.1007/s10853-006-1235-9

[14] R. Hergt and S. Dutz, Magnetic particle hyperthermia—biophysical limitations of a visionary tumour therapy. Journal of Magnetism and Magnetic Materials. 311 (2007) 187-192.

DOI: 10.1016/j.jmmm.2006.10.1156

[15] S. Laurent, S. Dutz, U.O. Häfeli and M. Mahmoudi, Magnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles. Advances in Colloid and Interface Science. 166 (2011) 8-23.

DOI: 10.1016/j.cis.2011.04.003

[16] E.J. Moon, P. Sonveaux, P.E. Porporato, P. Danhier, B. Gallez, I. Batinic-Haberle, Y.C. Nien, T. Schroeder and M.W. Dewhirst, NADPH oxidase-mediated reactive oxygen species production activates hypoxia-inducible factor-1 (HIF-1) via the ERK pathway after hyperthermia treatment. Proc. Natl. Acad. Sci. U. S. A. 107 (2010) PP20477–20482.

DOI: 10.1073/pnas.1006646107

[17] D. Trachootham, J. Alexandre and P. Huang, Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat. Rev. Drug Discovery. 8 (2009) 579.

DOI: 10.1038/nrd2803